Imaging Gauge Predicts Immunotherapy Resistance in Breast Cancer
Researchers develop an imaging-based immunosuppression gauge using CXCR2-expressing cells to monitor metastatic progression and treatment resistance.
Researchers develop an imaging-based immunosuppression gauge using CXCR2-expressing cells to monitor metastatic progression and treatment resistance.